Downstream PI3K, P38 signaling inhibition modulates cell survival, migration, invasion [42], and NF-κB activation [43], known to contribute to prostate cancer progression and castration resistance [44] through the regulation of AR activity [45]. Here, AR is linked to prostate cancer.